UASt sequences drive expression of full-length CG1139.
decreased cell number, with CG1139GS10666, Scer\GAL4Bx-MS1096
decreased cell number, with Scer\GAL4Bx-MS1096
decreased cell number, with Scer\GAL4en-e16E
decreased cell number (with CG1139GS10666), with Scer\GAL4Bx-MS1096
increased cell number, with Scer\GAL4GMR.PF
increased cell size, with Scer\GAL4en-e16E
eye, with Scer\GAL4GMR.PF
wing, with CG1139GS10666, Scer\GAL4Bx-MS1096
wing, with Scer\GAL4Bx-MS1096
wing, with Scer\GAL4en-e16E
wing (with CG1139GS10666), with Scer\GAL4Bx-MS1096
Expression of CG1139Scer\UAS.cGb, under the control of Scer\GAL4GMR.PF, causes overgrowth of the eye.
Overexpression of the CG1139Scer\UAS.cGb transgene throughout the developing adult wing, driven by Scer\GAL4Bx-MS1096, reduces wing growth and produces upturned wings.
Co-expression of CG1139GS10666 with CG1139Scer\UAS.cGb, driven by Scer\GAL4Bx-MS1096, enhanced the growth inhibitory effect of the CG1139Scer\UAS.cGb transgene.
Overexpression of CG1139Scer\UAS.cGb in the posterior wing compartment, driven by Scer\GAL4en-e16E, produces an increase in cell size even though overall wing area is reduced.